Healthcare Reform & the Future of the Pharma Supply Chain
We sat down with David Merrit, Executive Vice President of Public Affairs and Strategy, America's Health Insurance Plans to discuss Healthcare Reform. He said "The Trump Administration has put a very bright spotlight on rising prescription drug costs... Their focus has been on reducing regulation, increasing competition, and reducing what patients pay." Learn more about our conversation with David and hear what he has to say on:
- Healthcare Reform's affect on the pharma supply chain
- The national healthcare reform law affect on the future of the pharma supply Chain
- His advise on healthcare reform to the presidential campaigns
Please note: That all fields marked with an asterisk (*) are required.